# Church & Dwight Co Inc: Form 10-Q for the period ended Jun 30, 2015

- Company: [Church & Dwight Co Inc](/companies/chd.md) (CIK 313927)
- Form: 10-Q
- Filed: 2015-08-04
- Accepted by EDGAR: Aug 4, 2015, 18:11 ET
- Period: 2015-06-30
- Accession: 0001564590-15-006042
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/313927/000156459015006042/chd-10q_20150630.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/313927/000156459015006042/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2015-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2015-04-01 to 2015-06-30 | $847.1m | us-gaap:SalesRevenueGoodsNet |
| Revenue | 6 months, 2015-01-01 to 2015-06-30 | $1.66bn | us-gaap:SalesRevenueGoodsNet |
| Cost of revenue | 3 months, 2015-04-01 to 2015-06-30 | $474.0m | us-gaap:CostOfGoodsSold |
| Cost of revenue | 6 months, 2015-01-01 to 2015-06-30 | $930.8m | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months, 2015-04-01 to 2015-06-30 | $373.1m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2015-01-01 to 2015-06-30 | $728.6m | us-gaap:GrossProfit |
| Research and development | 3 months, 2015-04-01 to 2015-06-30 | $18.3m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months, 2015-01-01 to 2015-06-30 | $32.1m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2015-04-01 to 2015-06-30 | $115.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2015-01-01 to 2015-06-30 | $209.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2015-04-01 to 2015-06-30 | $142.3m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2015-01-01 to 2015-06-30 | $314.4m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2015-04-01 to 2015-06-30 | $7.9m | us-gaap:InterestExpense |
| Interest expense | 6 months, 2015-01-01 to 2015-06-30 | $15.5m | us-gaap:InterestExpense |
| Income tax | 3 months, 2015-04-01 to 2015-06-30 | $45.8m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2015-01-01 to 2015-06-30 | $103.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 6 months, 2015-01-01 to 2015-06-30 | $180.9m | us-gaap:ProfitLoss |
| Diluted EPS | 3 months, 2015-04-01 to 2015-06-30 | $0.55 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2015-01-01 to 2015-06-30 | $1.35 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2015-04-01 to 2015-06-30 | $0.56 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2015-01-01 to 2015-06-30 | $1.38 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2015-04-01 to 2015-06-30 | 133,400,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2015-01-01 to 2015-06-30 | 134,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2015-01-01 to 2015-06-30 | $248.4m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 6 months, 2015-01-01 to 2015-06-30 | $34.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months, 2015-01-01 to 2015-06-30 | $87.5m | us-gaap:PaymentsOfDividends |
| Share repurchases | 6 months, 2015-01-01 to 2015-06-30 | $263.1m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2015-06-30 | $203.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2015-06-30 | $848.1m | us-gaap:AssetsCurrent |
| Total assets | at 2015-06-30 | $4.23bn | us-gaap:Assets |
| Current liabilities | at 2015-06-30 | $885.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2015-06-30 | $2.26bn | us-gaap:Liabilities |
| Long-term debt | at 2015-06-30 | $700.1m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2015-06-30 | $250.0m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | at 2015-06-30 | $123.6m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2015-06-30 | $1.97bn | us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest |

## Management's discussion and analysis

As filed, 32,809 characters.

### RESULTS OF OPERATIONS

### Results of Operations

### Consolidated results

|  | Three Months Ended June 30, 2015 | Change vs. Prior Year | Three Months Ended June 30, 2014 |
| --- | ---: | ---: | ---: |
| **Net Sales** | **$847.1** | 4.8% | $808.3 |
| **Gross Profit** | **$373.1** | 4.7% | $356.4 |
| Gross Margin | **44.0%** | -10 basis points | 44.1% |
| **Marketing Expenses** | **$115.8** | 2.1% | $113.4 |
| Percent of Net Sales | **13.7%** | -30 basis points | 14.0% |
| **Selling, General & Administrative Expenses** | **$115.0** | 9.7% | $104.8 |
| Percent of Net Sales | **13.5%** | +50 basis points | 13.0% |
| **Income from Operations** | **$142.3** | 3.0% | $138.2 |
| Operating Margin | **16.8%** | -30 basis points | 17.1% |
|  | **Six Months Ended** | **Change vs.** | **Six Months Ended** |
|  | **June 30, 2015** | **Prior Year** | **June 30, 2014** |
| **Net Sales** | **$1,659.4** | 4.3% | $1,590.3 |
| **Gross Profit** | **$728.6** | 4.7% | $695.8 |
| Gross Margin | **43.9%** | +10 basis points | 43.8% |
| **Marketing Expenses** | **$204.6** | 1.7% | $201.2 |
| Percent of Net Sales | **12.3%** | -40 basis points | 12.7% |
| **Selling, General & Administrative Expenses** | **$209.6** | 7.8% | $194.4 |
| Percent of Net Sales | **12.7%** | +50 basis points | 12.2% |
| **Income from Operations** | **$314.4** | 4.7% | $300.2 |
| Operating Margin | **18.9%** | 0 basis points | 18.9% |

#### Net Sales

Net sales for the quarter ended June 30, 2015 were $847.1, an increase of $38.8 or 4.8% over the second quarter of 2014. Net sales for the six months ended June 30, 2015 were $1,659.4, an increase of $69.1 or 4.3% over the comparable six month period of 2014. The components of the net sales increase are as follows:

| Net Sales - Consolidated | Three Months Ended June 30, 2015 | Six Months Ended June 30, 2015 |
| --- | ---: | ---: |
| Product volumes sold | 4.5% | 3.9% |
| Pricing/Product mix | 0.6% | 0.5% |
| Foreign exchange rate fluctuations | (2.7)% | (2.5%) |
| Volume from acquired product lines (1) | 2.4% | 2.4% |
| **Net Sales increase** | **4.8%** | **4.3%** |

(1) On September 19, 2014, the Company acquired certain brands in the Lil’ Drug Store Brands Acquisition (the “LDS Acquisition”) and on January 2, 2015, the Company acquired certain assets of Varied Industries Corporation (the “VI-COR Acquisition”). Net sales of these acquisitions are included in the Company’s results since the date of acquisition.

For the three months ended June 30, 2015, the volume change primarily reflects increased product sales in both Consumer Domestic and Consumer International with volume declines in SPD. Favorable price/mix was recognized in all three segments for the three months. For the six months ended June 30, 2015, volume increases and favorable price/mix were recognized in all three segments.

#### Gross Profit / Gross Margin

The Company’s gross profit was $373.1 for the quarter ended June 30, 2015, a $16.7 increase as compared to the same period in 2014. The Company’s gross profit was $728.6 for the six month period ended June 30, 2015, a $32.8 increase as compared to the same period in 2014. Gross margin decreased 10 basis points (“bps”) in the second quarter of 2015 due to 30 bps associated with higher manufacturing costs (net of productivity programs and including higher than anticipated start-up costs associated with the Company’s new vitamin manufacturing facility) that were partially offset by lower commodity costs, and unfavorable foreign exchange rates of 30 bps, offset by favorable impact associated with the LDS and VI-COR Acquisitions of 40 bps, and the impact of higher volume, price and product mix of 10 bps. Gross margin increased 10 bps to 43.9% in the first six months of 2015 as compared to 43.8% in the same period of 2014. This is due to the favorable impact associated with the LDS and VI-COR Acquisitions of 40 bps, the impact of higher volume, price and product mix of 20 bps, partially offset by 20 bps due to higher manufacturing costs (net of productivity programs and including start-up costs associated with the Company’s new vitamin manufacturing facility) and lower commodity costs, and unfavorable foreign exchange rates of 30 bps.

#### Operating Expenses

Marketing expenses for the second quarter of 2015 were $115.8, an increase of $2.4 or 2.1% as compared to the same period in 2014. Marketing expenses as a percentage of net sales decreased 30 bps to 13.7% in the second quarter of 2015 as compared to 14.0% in the same period in 2014 due to 60 bps from leverage of expenses on higher sales, partially offset by 30 bps from a higher amount of marketing spending. Marketing expenses for the first six months of 2015 were $204.6, an increase of $3.4 as compared to the same period in 2014. Marketing expenses as a percentage of net sales were 12.3% in the first six months of 2015 as compared to 12.7% in the same period in 2014 due to 60 bps from leverage of expenses on higher sales, partially offset by 20 bps from a higher amount of marketing spending. The higher amount of marketing spending for both periods was primarily due to higher spending associated with the LDS acquisition.

Selling, general and administrative (“SG&A”) expenses were $115.0 in the second quarter of 2015, an increase of $10.2 or 9.7% as compared to the same period in 2014 primarily due to an $8.9 expense charge associated with the settlement of an international pension plan, and both on-going and one-time costs associated with the LDS Acquisition and VI-COR Acquisition. SG&A as a percentage of net sales increased 50 bps to 13.5% in the second quarter of 2015 as compared to 13.0% in the same period in 2014. The increase is due to the pension plan charge of approximately 110 bps, partially offset by 60 bps of leverage associated with higher sales. SG&A for the first six months of 2015 was $209.6, an increase of $15.2 as compared to the same period in 2015 due primarily to the same factors as those applicable to the second quarter of 2014. SG&A as a percentage of net sales was 12.7% in the first six months of 2015 as compared to 12.2% in the same period in 2014. The increase is due to the pension plan charge of approximately 60 bps and other cost increases of 40 bps, partially offset by 50 bps of leverage associated with higher sales.

#### Other Income and Expenses

Equity in earnings of affiliates for the three and six month periods ended June 30, 2015 decreased by $16.7 and $16.0 respectively, as compared to the same periods in 2014. The decrease in earnings was due primarily to a $17.0 impairment charge associated with the Company’s remaining investment in Natronx. This charge is primarily a result of lower than expected demand for the joint venture’s products as a result of a shift in the electric utility industry from coal-fired to natural gas-supplied power plants, continued delays in the implementation of updated federal regulations, and indirectly, the recent U.S. Supreme Court ruling against the Environmental Protection Agency (“EPA”) where the court stated that the EPA failed to properly consider the costs to implement the regulations. We believe that the foregoing factors will likely further delay the demand for these products.

Other expense for the three and six month periods ended June 30, 2015 increased $1.8 and $3.1 respectively, as compared to the same periods in 2014 due to the effect of changes in foreign currency rates.

Interest expense in the three and six month periods ended June 30, 2015 increased $1.0 and $1.9, respectively, as compared to the same period in 2014 due to the higher debt outstanding to fund the LDS and VI-COR Acquisitions.

#### Income Taxes

The effective tax rate in the three and six month periods ended June 30, 2015 was 38.3% and 36.5% respectively, compared to 34.2% and 34.4% respectively, in the same periods in 2014. During the quarter ended June 30, 2015, the Company reported an impairment charge of $17.0 relating to its investment in a joint venture. The Company recorded a valuation allowance against the resulting tax benefit which negatively impacted the tax rate for both the quarter and six month periods ended June 30, 2015. Also during the quarter ended June 30, 2015, the Company liquidated its subsidiary in the Netherlands and decided that the earnings of its subsidiary in France would no longer be permanently reinvested outside of the U.S. As a result of liquidating its subsidiary in the Netherlands, the Company recorded a tax benefit of $2.7 in the Consolidated Statement of Income in the quarter ended June 30, 2015.

### Segment results

The Company operates three reportable segments: Consumer Domestic, Consumer International and SPD. These segments are determined based on differences in the nature of products and organizational and ownership structures. The Company also has a Corporate segment.

| Segment | Products |
| --- | --- |
| Consumer Domestic | Household and personal care products |
| Consumer International | Primarily personal care products |
| SPD | Specialty chemical products |

The Corporate segment income consists of equity in earnings (losses) of affiliates. As of June 30, 2015, the Company held 50% ownership interests in each of Armand and ArmaKleen, respectively, and a one-third ownership interest in Natronx. The Company’s equity in earnings (losses) of Armand, ArmaKleen and Natronx for the three and six month periods ended June 30, 2015 and June 30, 2014 are included in the Corporate segment. See Note 17 for a discussion of the impairment charge which is included in the Corporate segment.

Some of the subsidiaries that are included in the Consumer International segment manufacture and sell personal care products to the Consumer Domestic segment. These sales are eliminated from the Consumer International segment results set forth below.

Segment net sales and income before income taxes for the three and six month periods ended June 30, 2015 and June 30, 2014 are as follows:

| Net Sales(1) | Consumer Domestic | Consumer International | SPD | Corporate(3) | Total |
| --- | ---: | ---: | ---: | ---: | ---: |
| **Second Quarter 2015** | **$638.3** | **$130.9** | **$77.9** | **$0.0** | **$847.1** |
| Second Quarter 2014 | 598.9 | 136.6 | 72.8 | 0.0 | 808.3 |
| **First Six Months of 2015** | **$1,252.9** | **$251.3** | **$155.2** | **$0.0** | **$1,659.4** |
| First Six Months of 2014 | 1,192.2 | 260.4 | 137.7 | 0.0 | 1,590.3 |
| **Income before Income Taxes(2)** |  |  |  |  |  |
| **Second Quarter 2015** | **$112.6** | **$4.5** | **$16.1** | **$(13.7)** | **$119.5** |
| Second Quarter 2014 | 107.7 | 14.3 | 10.1 | 2.9 | 135.0 |
| **First Six Months of 2015** | **$242.2** | **$23.9** | **$30.1** | **$(11.4)** | **$284.8** |
| First Six Months of 2014 | 234.6 | 32.5 | 20.1 | 4.5 | 291.7 |

(1) Intersegment sales from Consumer International to Consumer Domestic, which are not reflected in the table, were $1.7 and $0.3 for the quarter ended June 30, 2015 and June 30, 2014, respectively, and were $3.0 and $0.5 for the six months ended June 30, 2015 and June 30, 2014, respectively.

(2) In determining Income before Income Taxes, interest expense and investment earnings were allocated among the segments based upon each segment’s relative Income from Operations.

(3) Corporate segment consists of equity in earnings (losses) of affiliates from Armand, ArmaKleen and Natronx.

Product line revenues from external customers are as follows:

|  | Three Months Ended June 30, 2015 | June 30, 2014 | Six Months Ended June 30, 2015 | June 30, 2014 |
| --- | ---: | ---: | ---: | ---: |
| Household Products | **$390.9** | $355.2 | **$757.4** | $707.7 |
| Personal Care Products | **247.4** | 243.7 | **495.5** | 484.5 |
| Total Consumer Domestic | **638.3** | 598.9 | **1,252.9** | 1,192.2 |
| Total Consumer International | **130.9** | 136.6 | **251.3** | 260.4 |
| Total SPD | **77.9** | 72.8 | **155.2** | 137.7 |
| **Total Consolidated Net Sales** | **$847.1** | $808.3 | **$1,659.4** | $1,590.3 |

Household Products include laundry, deodorizing, and cleaning products. Personal Care Products include condoms, pregnancy kits, oral care products, skin care products and gummy dietary supplements.

### Consumer Domestic

Consumer Domestic net sales in the second quarter of 2015 were $638.3, an increase of $39.4 or 6.6% as compared to the same period in 2014. Consumer Domestic net sales for the six months ended June 30, 2015 were $1,252.9, an increase of $60.7 or 5.1% as compared to the same period in 2014. The components of the net sales change are the following:

| Net Sales - Consumer Domestic | Three Months Ended June 30, 2015 | Six Months Ended June 30, 2015 |
| --- | ---: | ---: |
| Product volumes sold | 4.5% | 2.9% |
| Pricing/Product mix | 0.2% | 0.2% |
| Volume from acquired product lines (1) | 1.7% | 1.8% |
| Other | 0.2% | 0.2% |
| **Net Sales increase** | **6.6%** | **5.1%** |

(1) Includes net sales of the brands acquired in the LDS Acquisition since the date of acquisition.

Other than sales from the LDS Acquisition, the increase in net sales for the three and six month periods ending June 30, 2015, reflects higher sales for the ARM & HAMMER CLUMP & SEAL cat litter product lines including the new lightweight variant launched in December 2014, ARM & HAMMER liquid laundry detergent, OXICLEAN laundry detergent and BATISTE dry shampoo, partially offset by lower sales of L’IL CRITTERS and VITAFUSION gummy dietary supplements and XTRA laundry detergent. OXICLEAN laundry detergent sales in the first quarter of 2014 included initial inventory purchases by our customers.

Since the 2012 introduction in the U.S. of unit dose laundry detergent by various manufacturers, including the Company, there has been significant product and price competition in the laundry detergent category, contributing to an overall category decline. In 2014, the Procter & Gamble Company, one of the Company’s major competitors and the market leader in laundry detergent, took several competitive actions, including launching a lower-priced line of laundry detergents that competes directly with the Company’s core value laundry detergents. In the first quarter of 2015, the competitive environment intensified as Henkel AG & Co. KGaA entered the U.S. market with Persil, its leading premium laundry detergent around the world. While it is too early to assess what impact this will have on the premium laundry category or the Company’s laundry detergent business, the introduction of Persil could precipitate greater price competition in the category with a potential adverse impact on OXICLEAN laundry detergent. The Company continues to evaluate and vigorously combat the pressures in the laundry detergent category through, among other things, new product introductions and increased marketing spending. Despite that category being flat for the first six months and recent category growth in the second quarter, after declines in 2013 and 2014, there is no assurance the category will not decline further and that the Company will be able to offset any such category decline.

Additionally, delays in the Company’s second quarter start-up of the new vitamin manufacturing facility have resulted in the need to place certain retailers on allocation, which has led to increased retailer scrutiny of our products. Production rates are increasing and we expect to improve customer service levels. If, however, the Company were to lose a significant customer or if sales of its vitamin products were to materially decrease due to customer service levels or real or perceived quality issues, it could have a material adverse effect on the Company’s business, financial condition and results of operations.

Consumer Domestic income before income taxes for the second quarter of 2015 was $112.6, a $4.9 increase as compared to the second quarter of 2014. The increase is due primarily to the impact of higher sales volumes of $20.8, partially offset by higher SG&A costs of $3.9, marketing costs of $3.6 and $6.1 of higher manufacturing costs (including the vitamin manufacturing start-up costs and productivity programs) that were partially offset by lower commodity costs. For the six-month period ended June 30, 2015, income before income taxes was $242.2, a $7.6 increase as compared to the first six months of 2014. The increase is due primarily to the impact of higher sales volumes of $32.6, partially offset by higher SG&A costs of $10.6, marketing costs of $3.3 and $9.1 of higher manufacturing costs (including the vitamin manufacturing start-up costs and productivity programs) that were partially offset by lower commodity costs.

### Consumer International

Consumer International net sales were $130.9 in the second quarter of 2015, a decrease of $5.7 or 4.2% as compared to the same period in 2014. Consumer International net sales in the first six months of 2015 were $251.3, a decrease of $9.1 or approximately 3.5% as compared to the same period in 2014. The components of the net sales change are the following:

| Net Sales - Consumer International | Three Months Ended June 30, 2015 | Six Months Ended June 30, 2015 |
| --- | ---: | ---: |
| Product volumes sold | 7.3% | 8.8% |
| Pricing/Product mix | 2.3% | 0.8% |
| Foreign exchange rate fluctuations / Other | (15.3%) | (14.5%) |
| Volume from acquired product lines (1) | 1.5% | 1.4% |
| **Net Sales (decrease )** | **(4.2%)** | (3.5%) |

(1) Includes net sales of the brands acquired in the LDS Acquisition since the date of acquisition.

Excluding the impact of unfavorable foreign exchange rates, higher sales in the second quarter of 2015 occurred primarily in Europe, Mexico and U.S. exports. Higher sales in the first six months of 2015 occurred primarily in Europe, U.S. exports and Mexico.

Consumer International income before income taxes was $4.5 in the second quarter of 2015, a decrease of $9.8 compared to the same period in 2014 due primarily to the $8.9 pension settlement charge, the impact of unfavorable exchange rates of $4.5 and higher marketing costs of $1.8, partially offset by higher volumes of $5.8. For the first six months of 2015, income before income taxes was $23.9, an $8.6 decrease as compared to the same period of 2014, due primarily to the $8.9 pension settlement charge, the impact of unfavorable exchange rates of $8.8, higher marketing costs of $4.5, partially offset by higher volumes of $12.5.

### Specialty Products (“SPD”)

SPD net sales were $77.9 for the second quarter of 2015, an increase of $5.1 or 7.0% as compared to the same period in 2014. SPD net sales were $155.2 for the first six months of 2015, an increase of $17.5, or 12.7% as compared to the same period of 2014. The components of the net sales change are the following:

| Net Sales - SPD | Three Months Ended June 30, 2015 | Six Months Ended June 30, 2015 |
| --- | ---: | ---: |
| Product volumes sold | (0.8%) | 3.2% |
| Pricing/Product mix | 0.7% | 1.7% |
| Foreign exchange rate fluctuations / Other | (3.0%) | (2.4)% |
| Volume from acquired product lines (1) | 10.1% | 10.2% |
| **Net Sales increase** | **7.0%** | **12.7%** |

(1) Net sales of the VI-COR Acquisition are included in the Company’s results since the date of acquisition.

The net sales increase in the second quarter of 2015 reflects higher sales in the chemicals business and the VI-COR animal nutrition acquisition, partially offset by lower sales in the existing animal nutrition business. The increase in net sales for the six months ended June 30, 2015 is due primarily to the same factors as those applicable to the second quarter of 2015.

SPD income before income taxes was $16.1 in the second quarter of 2015, an increase of $6.0 as compared to the same period in 2014 due primarily to higher sales volume of $4.6, and lower manufacturing costs of $3.7, partially offset by higher SG&A expenses of $1.9. For the first six months of 2015, income before income taxes was $30.1, an increase of $10.0 as compared to the same period in 2014 due primarily to higher sales volume of $10.1, lower manufacturing costs of $5.9, favorable price/mix of $2.3, partially offset by unfavorable foreign currency rates of $3.6 and higher SG&A of $3.8.

### Corporate

The administrative costs of the Company’s production, planning and logistics functions are included in the SG&A expenses of each operating segment and as elements of cost of sales in the Company’s Consolidated Statements of Income. The Corporate segment includes equity in earnings (losses) of affiliates from Armand, ArmaKleen and Natronx. The Corporate segment income before income taxes was a loss of $13.7 in the second quarter of 2015, a decrease of $16.6 as compared to the same period in 2014. The Corporate segment income before income taxes was a loss of $11.4 for the first six months of 2015, a decrease of $15.9 as compared to the same period in 2014. The decrease in both periods is a result of the $17.0 Natronx impairment charge.

### Liquidity and capital resources

As of June 30, 2015, the Company had $203.2 in cash and cash equivalents, approximately $470.0 available through the revolving facility under its principal credit agreement (the “Credit Agreement”) and its commercial paper program, and a commitment increase feature under the Credit Agreement that enables the Company to borrow up to an additional $500.0, subject to lending commitments of the participating lenders and certain conditions as described in the Credit Agreement. To preserve its liquidity, the Company invests its cash primarily in prime money market funds and short term bank deposits.

During the quarter ended June 30, 2015, the Company liquidated its subsidiary in the Netherlands and decided that the earnings of its subsidiary in France would no longer be permanently reinvested outside of the U.S. As a result, the Company repatriated cash of $93.0. The funds repatriated were used to reduce outstanding commercial paper. As a result of liquidating its subsidiary in the Netherlands, the Company recorded a tax benefit of $2.7 in the Consolidated Statement of Income and a deferred tax benefit of $11.6 recorded through Accumulated Other Comprehensive Income in the quarter ended June 30, 2015. As of June 30, 2015, there remains $149.2 of cash and cash equivalents outside the U.S. These funds are not needed for operations in the U.S. If they were, the Company would be required to accrue and pay taxes in the U.S. to repatriate these funds. The Company’s intent is to permanently reinvest these funds outside the U.S., and the Company does not currently expect to repatriate them to fund U.S. operations.

The current economic environment presents risks that could have adverse consequences for the Company’s liquidity. (See “Unfavorable economic conditions could adversely affect demand for the Company’s products” under “Risk Factors” in Item 1A of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2014 (the “Form 10-K”).) The Company does not anticipate that current economic conditions will adversely affect its ability to comply with the financial covenant in the Credit Agreement because the Company currently is, and anticipates that it will continue to be, in compliance with the maximum leverage ratio requirement under the Credit Agreement.

On January 28, 2015, the Board declared an 8% increase in the regular quarterly dividend from $0.31 to $0.335 per share, equivalent to an annual dividend of $1.34 per share as of February 10, 2015. The decision raised the annual dividend payout from $168.0 to approximately $177.0.

On January 29, 2014, the Company authorized an evergreen share repurchase program to reduce or eliminate dilution associated with the issuance of Common Stock under the Company’s incentive plans. As part of the evergreen share repurchase program, in January 2015, the Company repurchased 0.5 million shares at a cost of $41.2. On January 28, 2015, the Board authorized a share repurchase program under which the Company may repurchase up to $500.0 in shares of Common Stock (the “2015 Share Repurchase Program”). In February 2015, the Company entered into an accelerated share repurchase contract with a commercial bank to repurchase 2.6 million shares of Common Stock at a cost of $215.0, of which approximately $47.0 was purchased under the evergreen share repurchase program and approximately $168.0 was purchased under the 2015 Share Repurchase Program. Under the terms of the accelerated share repurchase contract, upon final settlement of the contract, the Company would receive additional shares, or, if the Company is required to deliver additional value to the bank, the Company would pay additional shares or cash to the bank based on the average market price of Common Stock over the repurchase period. On April 24, 2015, the settlement date, the Company issued 83 thousand shares of Common Stock to the commercial bank in a private transaction for approximately $7.0 to settle the accelerated share repurchase contract. On May 18, 2015, the Company repurchased the 83 thousand shares from the commercial bank for approximately $7.0 pursuant to the terms of the accelerated share repurchase contract.

The Company anticipates that its available cash and cash from operations will be sufficient to meet its capital expenditure program costs, which are expected to be approximately $70.0 in 2015, fund the 2015 Share Repurchase Program and the evergreen share repurchase program to the extent implemented by management, pay dividends at the latest approved rate and fund cash contributions to benefit plans. Cash, together with the Company’s current borrowing capacity, may be used for acquisitions that would complement the Company’s existing product lines or geographic markets.

The Company also anticipates that it will generate sufficient cash from operations during the remainder of 2015 that, combined with a portion of its existing cash balance, will enable the Company to fully repay the $250.0 of 3.35% Senior Notes due on December 15, 2015.

#### Net Debt

The Company had outstanding total debt of $1,073.7 and cash of $203.2, resulting in net debt of $870.5 at June 30, 2015. This compares to total debt of $1,095.2 and cash of $423.0, resulting in net debt of $672.2 at December 31, 2014. Net debt is defined as the sum of short-term debt and long-term debt, minus cash and cash equivalents.

#### Cash Flow Analysis

|  | Six Months Ended June 30, 2015 | June 30, 2014 |
| --- | ---: | ---: |
| Net cash provided by operating activities | **$248.4** | $206.8 |
| Net cash used in investing activities | **$(110.9)** | $(18.0) |
| Net cash used in financing activities | **$(347.9)** | $(490.3) |

**Net Cash Provided by Operating Activities –** The Company’s primary source of liquidity is the strong cash flow provided by operating activities, which is dependent on the level of net income and changes in working capital. The Company’s net cash provided by operating activities in the first six months of 2015 increased by $41.6 to $248.4 as compared to the same period in 2014 due to higher cash earnings (net income plus non-cash expenses such as depreciation, amortization, non-cash compensation and asset impairment charges). The Company measures working capital effectiveness based on its cash conversion cycle. The Company's cash conversion cycle, (defined as days in accounts receivable plus days in inventory less days in accounts payable) which is calculated using a 2 quarter average method, improved 9 days from the prior year amount of 39 days to 30 days at the end of the second quarter of 2015 due to improvements in accounts receivable of 2 days, inventories of 3 days and accounts payable of 4 days. The improvement in the Company's cash conversion cycle reflects the Company's focus on reducing its average working capital requirements.

**Net Cash Used in Investing Activities –** Net cash used in investing activities during the first six months of 2015 was $110.9, principally reflecting $74.9 for the VI-COR Acquisition and $34.0 for property, plant and equipment expenditures, in large part due to the Company’s new gummy vitamin manufacturing facility in York, Pennsylvania.

**Net Cash Used in Financing Activities –** Net cash used in financing activities during the first six months of 2015 was $347.9, primarily reflecting $263.1 of repurchases of Common Stock, $87.5 of cash dividends and repayment of $23.0 of commercial paper borrowings, offset by $26.4 of proceeds and tax benefits from stock option exercises. The smaller amount of net cash used in the six months ended June 30, 2015 as compared to last year reflects the reduction in treasury stock purchases, partially offset by higher debt payments.

### Financial Covenant

“Consolidated EBITDA” (referred to below as “Adjusted EBITDA” and defined in the Credit Agreement that was revised in December 2014) is a component of the financial covenant contained in the Credit Agreement. The financial covenant includes a leverage ratio (total debt to Adjusted EBITDA), which, if not met, could result in an event of default and trigger the early termination of the Credit Agreement. Adjusted EBITDA may not be comparable to similarly titled measures used by other entities and should not be considered as an alternative to cash flows from operating activities determined in accordance with accounting principles generally accepted in the U.S. The Company’s leverage ratio for the twelve months ended June 30, 2015 was 1.47, which is below the maximum of 3.75 permitted under the Credit Agreement.

### New Accounting Pronouncements

In May 2014, the Financial Accounting Standards Board (“FASB”) issued guidance that clarifies the principles for recognizing revenue. The guidance provides that an entity should recognize revenue for the transfer of goods or services equal to the amount that it expects to receive for those goods or services. The guidance is effective for annual and interim periods beginning after December 15, 2017, and allows companies to apply the requirements retrospectively, either to all prior periods presented or through a cumulative adjustment in the year of adoption. Early adoption is allowed for annual and interim periods beginning after December 15, 2016. The Company is currently evaluating the impact, if any, that the adoption of the guidance will have on its consolidated financial position, results of operations or cash flows.

In April 2015, the FASB issued guidance that changes the presentation of debt issuance costs in the financial statements. The guidance requires debt issuance costs to be presented as a direct deduction from the associated debt liability rather than as an asset. Amortization of the costs will continue to be reported as interest expense. The guidance is effective for annual reporting periods beginning after December 15, 2016, and will be applied retrospectively for each prior period presented in the financial statements. This guidance is not expected to have a material impact on the Company’s consolidated financial position, results of operations or cash flows.

In April 2015, the FASB issued guidance that clarifies the accounting treatment for cloud computing arrangements. The guidance provides that if an arrangement includes a software license, then the software license element should be accounted for consistent with the acquisition of other software licenses. If the arrangement does not include a software license, the arrangement should be accounted for as a service contract. This guidance is effective for interim and annual periods beginning after December 15, 2015, and may be applied retrospectively or prospectively. This guidance is not expected to have a material impact on the Company’s consolidated financial position, results of operations or cash flows.

In July 2015, the FASB issued guidance on simplifying the measurement of inventory. Inventory within the scope of this update is required to be measured at the lower of its cost or net realizable value, with net realizable value being the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. The guidance is effective for interim and annual periods beginning after December 15, 2016, with early adoption permitted, and will be applied prospectively. The Company is currently evaluating the impact, if any, that the adoption of the guidance will have on its consolidated financial position, results of operations or cash flows.

There have been no accounting pronouncements issued but not yet adopted by the Company which are expected to have a material impact on the Company’s consolidated financial position, results of operations or cash flows.

## Market risk

As filed, 3,580 characters.

### Market risk

#### Interest Rate Risk

The Company had outstanding total debt at June 30, 2015 of $1,073.7, of which 88% has a fixed weighted average interest rate of 2.87% and the remaining 12% constituted principally commercial paper issued by the Company that currently has a weighted average interest rate of less than 0.6%. In December 2014, the Company entered into interest rate swap agreements on an aggregate notional amount of $300.0 to convert the fixed interest rate on the Senior Notes due in 2019 to a variable interest rate.

#### Diesel Fuel Hedges

The Company uses independent freight carriers to deliver its products. These carriers currently charge the Company a basic rate per mile for diesel fuel price increases. During 2014, the Company entered into hedge agreements with financial counterparties to mitigate the volatility of diesel fuel prices, and not to speculate in the future price of diesel fuel. Under the hedge agreements, the Company agreed to pay a fixed price per gallon of diesel fuel determined at the time the agreements were executed and to receive a floating rate payment that is determined on a monthly basis based on the average price of the Department of Energy’s Diesel Fuel Index during the applicable month and is designed to offset any increase or decrease in fuel costs that the Company pays to its common carriers. The agreements are expected to cover approximately 63% of the Company’s 2015 diesel fuel requirements and approximately 32% of the Company’s estimated diesel fuel requirements for 2016. These diesel fuel hedge agreements qualify for hedge accounting. Therefore, changes in the fair value of such agreements are recorded under Accumulated Other Comprehensive Income on the balance sheet.

#### Foreign Currency

The Company is subject to exposure from fluctuations in foreign currency exchange rates, primarily U.S. Dollar/Euro, U.S. Dollar/British Pound, U.S. Dollar/Canadian Dollar, U.S. Dollar/Mexican Peso, U.S. Dollar/Australian Dollar, U.S. Dollar/Brazilian Real and U.S. Dollar/Chinese Yuan.

The Company enters into forward exchange contracts to reduce the impact of foreign exchange rate fluctuations related to anticipated but not yet committed sales or purchases denominated in U.S. Dollar, Canadian Dollar, British Pound and Euro. The Company entered into forward exchange contracts to protect itself from the risk that, due to changes in currency exchange rates, it would be adversely affected by net cash outflows. The face value of the unexpired contracts as of June 30, 2015 was $169.4, of which $121.0 qualify as foreign currency cash flow hedges and, therefore, changes in the fair value of the contracts are recorded in Other Comprehensive Income (Loss) and reclassified to earnings when the hedged transactions affect earnings. The agreements cover almost all of the expected intercompany purchases made by the Company’s Canadian subsidiary for the balance of 2015 and 2016.

#### Equity Derivatives

The Company has entered into equity derivative contracts covering its stock in order to minimize the liability resulting from changes in the quoted fair values of such stock to participants in its Executive Deferred Compensation Plan who have investments under that Plan in a notional Company stock fund. These equity derivative contracts are typically settled in cash. Since the equity derivatives do not qualify for hedge accounting, the Company is required to mark the contracts to market throughout the life of the contracts and record changes in fair value in the consolidated statement of income.

## Controls and procedures

As filed, 5,170 characters.

a) Evaluation of Disclosure Controls and Procedures

The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) at the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures, as of the end of the period covered by this report, are effective to provide reasonable assurance that the information required to be disclosed by the Company in reports filed under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the rules and forms of the United States Securities and Exchange Commission (the “Commission”), and (ii) accumulated and communicated to the Company’s management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding the disclosure.

b) Change in Internal Control over Financial Reporting

No change in the Company’s internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the Company’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

### CAUTIONARY NOTE ON FORWARD-LOOKING INFORMATION

This report contains forward-looking statements, including, among others, statements relating to sales and earnings growth; the effect of product mix; volume growth, including the effects of new product launches into new and existing categories; the impact of unit dose laundry detergent; the effects of competition; earnings per share; gross margin changes including the vitamin manufacturing start-up costs; trade and marketing spending; marketing expense as a percentage of net sales; cost savings programs; the Company’s hedge programs; the impact of foreign exchange and commodity price fluctuations; the impact of a pension settlement charge; the Company’s share repurchase programs; the impact of acquisitions; capital expenditures; the effective tax rate; tax changes; environmental and regulatory matters; the effect of the credit environment on the Company’s liquidity and capital expenditures; the Company’s fixed rate debt; compliance with covenants under the Company’s Credit Agreement and other debt instruments; the Company’s commercial paper program; sufficiency of cash flows from operations; the Company’s current and anticipated future borrowing capacity to meet capital expenditure program costs; payment of dividends; actual and expected cash contributions to pension plans; investments in the Natronx Technologies, LLC joint venture; and availability and adequacy of raw materials. These statements represent the intentions, plans, expectations and beliefs of the Company, and are based on assumptions that the Company believes are reasonable but may prove to be incorrect. In addition, these statements are subject to risks, uncertainties and other factors, many of which are outside the Company’s control and could cause actual results to differ materially from such forward-looking statements. Factors that might cause such differences include a decline in market growth, retailer distribution and consumer demand (as a result of, among other things, political, economic and marketplace conditions and events); unanticipated increases in raw material and energy prices; adverse developments affecting the financial condition of major customers and suppliers; competition, including The Procter & Gamble Company’s participation in the value laundry detergent category and Henkel AG & Co. KGaA’s entrance into the U.S. laundry detergent market with Persil, its leading premium laundry detergent around the world; changes in marketing and promotional spending; growth or declines in various product categories and the impact of customer actions in response to changes in consumer demand and the economy, including increasing shelf space of private label products; consumer and competitor reaction to, and customer acceptance of, new product introductions and features; disruptions in the banking system and financial markets; foreign currency exchange rate fluctuations; the impact of natural disasters on the Company and its customers and suppliers, including third party information technology service providers; the acquisition or divestiture of assets; the outcome of contingencies, including litigation, pending regulatory proceedings and environmental matters; and changes in the regulatory environment.

The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by the U. S. federal securities laws. You are advised, however, to consult any further disclosures the Company makes on related subjects in its filings with the Commission.

## Risk factors

As filed, 252 characters.

In addition to the other information set forth in this report, you should carefully consider the factors discussed in Item 1A, “Risk Factors” in the Form 10-K, which could materially affect the Company’s business, financial condition or future results.

Filed Aug 4, 2015.
Source: SEC EDGAR, the filing index for accession 0001564590-15-006042. Last ingested by Listed: Nov 14, 2026, 21:34 ET. No prices; not investment advice.
